Literature DB >> 35991728

Acquired hemophilia A after vaccination against SARS-CoV-2 with the mRNA-1273 (Moderna) vaccine.

Ava Melmed1, Andrew Kovoor2, Korie Flippo2.   

Abstract

Acquired hemophilia A is a rare bleeding diathesis most typically seen in systemic rheumatic disease, solid and hematologic malignancies, and pregnancy. We present a case of this condition that occurred immediately after vaccination against SARS-CoV-2 with the mRNA-1273 (Moderna) vaccine.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Acquired hemophilia A; COVID-19; SARS-CoV-2; mRNA vaccination; vaccine reactions

Year:  2022        PMID： 35991728      PMCID： PMC9373746          DOI： 10.1080/08998280.2022.2071121

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  10 in total

1.  Acquired factor VIII haemophilia following influenza vaccination.

Authors:  Guillaume Moulis; Grégory Pugnet; Haleh Bagheri; Claire Courtellemont; Antoine Huart; Dominique Chauveau; Jacques Pourrat; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2010-06-27       Impact factor: 2.953

2.  The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.

Authors:  Micol G Cittone; Raphael Battegay; Adalgisa Condoluci; Lodovico Terzi di Bergamo; Eliana Fernandes; Elena Galfetti; Roberta Noseda; Anne Leuppi-Taegtmeyer; Beatrice Drexler; Ceschi Alessandro; Dimitrios A Tsakiris; Christoph T Berger; Genevieve Favre; Thomas Martin; Wolfgang Korte; Lukas Graf; Maria Martinez; Bernhard Gerber
Journal:  J Thromb Haemost       Date:  2021-06-08       Impact factor: 5.824

Review 3.  Vaccination and autoimmune disease: what is the evidence?

Authors:  David C Wraith; Michel Goldman; Paul-Henri Lambert
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

Review 4.  Acquired factor VIII inhibitors.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood       Date:  2008-05-07       Impact factor: 22.113

5.  A case report of acquired hemophilia following COVID-19 vaccine.

Authors:  Mansoor Radwi; Sara Farsi
Journal:  J Thromb Haemost       Date:  2021-05-10       Impact factor: 5.824

6.  The first case of acquired hemophilia A associated with SARS-CoV-2 infection.

Authors:  Massimo Franchini; Claudia Glingani; Giuseppe De Donno; Salvatore Casari; Beatrice Caruso; Isabella Terenziani; Cesare Perotti; Claudia Del Fante; Filippo Sartori; Mauro Pagani
Journal:  Am J Hematol       Date:  2020-05-13       Impact factor: 10.047

7.  Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.

Authors:  Viktorija Erdeljic Turk
Journal:  Clin Immunol       Date:  2021-04-28       Impact factor: 3.969

8.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

9.  Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine.

Authors:  Maria Cristina Leone; Simone Canovi; Annalisa Pilia; Annamaria Casali; Luca Depietri; Tommaso Fasano; Rossana Colla; Angelo Ghirarduzzi
Journal:  Thromb Res       Date:  2022-01-20       Impact factor: 3.944

10.  Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.

Authors:  Julia R Hirsiger; Maria Martinez; Dimitrios A Tsakiris; Micol G Cittone; Lukas Graf; Johannes Oldenburg; Behnaz Pezeshkpoor; Mike Recher; Jens Mueller; Bernhard Gerber; Christoph T Berger
Journal:  J Thromb Haemost       Date:  2022-02-13       Impact factor: 16.036
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.